University Hospital Ostrava
University Hospital Ostrava
Ostrava, Czechia5 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of the Safety and Efficacy of Parecoxib in Patients With Subarachnoid Hemorrhage | Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms | Recruiting | Phase 2 | 2026-08-21 | NCT06579274 | |
| Daratumumab-bortezomib-dexamethasone (Dara-VCd) vs Bortezomib-Thalidomide-Dexamethasone (VTd), Then Maintenance With Ixazomib (IXA) or IXA-Dara | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, disease, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Active, not recruiting | Phase 2 | 2026-07-16 | NCT03896737 | |
| Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, primary myelofibrosis | Recruiting | Phase 3 | 2025-09-25 | NCT06479135 | |
| A Study to Assess Patient-Reported Wellbeing Using Tildrakizumab in a Live Setting | Plaque Psoriasis | Active, not recruiting | Not stated | 2025-06-24 | NCT06488170 | |
| Gastric Pathophysiology in Diabetes | Digestive System Diseases, Neurologic Manifestations, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, autoimmune disease, diabetes mellitus, digestive system disorder, endocrine system disorder, gastroparesis, glucose metabolism disease, immune system disorder, metabolic disease, palsy, stomach disorder, type 1 diabetes mellitus, type 2 diabetes mellitus | Recruiting | Not stated | 2024-05-17 | NCT06068114 |